HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Moringin/α-CD Pretreatment Induces Neuroprotection in an In Vitro Model of Alzheimer's Disease: A Transcriptomic Study.

Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and represents the most common form of senile dementia. Autophagy and mitophagy are cellular processes that play a key role in the aggregation of β-amyloid (Aβ) and tau phosphorylation. As a consequence, impairment of these processes leads to the progression of AD. Thus, interest is growing in the search for new natural compounds, such as Moringin (MOR), with neuroprotective, anti-amyloidogenic, antioxidative, and anti-inflammatory properties that could be used for AD prevention. However, MOR appears to be poorly soluble and stable in water. To increase its solubility MOR was conjugated with α-cyclodextrin (MOR/α-CD). In this work, it was evaluated if MOR/α-CD pretreatment was able to exert neuroprotective effects in an AD in vitro model through the evaluation of the transcriptional profile by next-generation sequencing (NGS). To induce the AD model, retinoic acid-differentiated SH-SY5Y cells were exposed to Aβ1-42. The MOR/α-CD pretreatment reduced the expression of the genes which encode proteins involved in senescence, autophagy, and mitophagy processes. Additionally, MOR/α-CD was able to induce neuronal remodeling modulating the axon guidance, principally downregulating the Slit/Robo signaling pathway. Noteworthy, MOR/α-CD, modulating these important pathways, may induce neuronal protection against Aβ1-42 toxicity as demonstrated also by the reduction of cleaved caspase 3. These data indicated that MOR/α-CD could attenuate the progression of the disease and promote neuronal repair.
AuthorsSerena Silvestro, Luigi Chiricosta, Agnese Gugliandolo, Renato Iori, Patrick Rollin, Daniele Perenzoni, Fulvio Mattivi, Placido Bramanti, Emanuela Mazzon
JournalCurrent issues in molecular biology (Curr Issues Mol Biol) Vol. 43 Issue 1 Pg. 197-214 (May 26 2021) ISSN: 1467-3045 [Electronic] Switzerland
PMID34073287 (Publication Type: Journal Article)
Chemical References
  • Cyclodextrins
  • Isothiocyanates
  • Neuroprotective Agents
  • moringin
Topics
  • Alzheimer Disease (drug therapy, metabolism, pathology, prevention & control)
  • Cyclodextrins (chemistry)
  • Humans
  • Isothiocyanates (chemistry, pharmacology)
  • Neuronal Plasticity
  • Neuroprotective Agents (pharmacology)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: